HOOKIPA Pharma Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

HOOKIPA Pharma Inc. reported Cash And Cash Equivalents At Carrying Value of $39.68 million for the year ending 2024.

  • HOOKIPA Pharma Inc. showed a decrease of -66.1% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
  • XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2018 to 2024), HOOKIPA Pharma Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 18.3%.
  • Historical annual values: Fiscal year 2024: $39.68 million | Fiscal year 2023: $117.10 million | Fiscal year 2022: $112.49 million | Fiscal year 2021: $65.92 million | Fiscal year 2020: $142.74 million | Fiscal year 2019: $113.15 million | Fiscal year 2018: $48.58 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: